UPDATED Oct 30, 2023
Discover large cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2269WuXi Biologics (Cayman) | HK$50.50 | 9.5% | 42.3% | HK$214.7b | HK$74.13 | PE48.4x | E23.0% | n/a | ||
| 3692Hansoh Pharmaceutical Group | HK$14.96 | 31.7% | 23.4% | HK$88.6b | HK$15.47 | PE32.2x | E11.8% | 0.9% | ||
| 1093CSPC Pharmaceutical Group | HK$6.70 | 20.1% | -17.0% | HK$79.4b | HK$9.46 | PE12.2x | E2.2% | 4.1% | ||
| 1801Innovent Biologics | HK$47.05 | 6.7% | 69.2% | HK$75.8b | HK$51.30 | PS14.1x | E63.9% | n/a | ||
| 1177Sino Biopharmaceutical | HK$3.09 | 15.7% | -18.9% | HK$56.9b | HK$5.54 | PE28.3x | E18.9% | 2.6% | ||
| 1548Genscript Biotech | HK$22.20 | 16.5% | 11.9% | HK$47.1b | HK$28.63 | PS8.5x | E55.2% | 0% | ||
| 1877Shanghai Junshi Biosciences | HK$21.45 | 19.6% | -21.9% | HK$42.1b | HK$32.72 | PS16.2x | E55.7% | n/a | ||
| 9926Akeso | HK$43.25 | 14.6% | 37.3% | HK$36.4b | HK$53.68 | PE17.1x | E-25.3% | n/a | ||
| 9995RemeGen | HK$42.85 | 15.8% | -13.3% | HK$32.1b | HK$54.90 | PS25.7x | E61.0% | n/a | ||
| 3320China Resources Pharmaceutical Group | HK$4.99 | 8.0% | -5.8% | HK$31.3b | HK$8.07 | PE7.5x | E13.5% | 3.2% | ||
| 867China Medical System Holdings | HK$12.76 | 12.3% | 48.9% | HK$31.3b | HK$17.69 | PE8.7x | E9.8% | 4.8% | ||
| 570China Traditional Chinese Medicine Holdings | HK$3.82 | 11.4% | 12.7% | HK$19.2b | HK$4.30 | PE19.4x | E26.3% | 1.3% | ||
| 2096Simcere Pharmaceutical Group | HK$6.85 | 7.9% | -21.4% | HK$18.0b | HK$10.62 | PE5.3x | E-24.1% | 2.5% | ||
| 6990Sichuan Kelun-Biotech Biopharmaceutical | HK$81.80 | 12.7% | n/a | HK$17.9b | HK$120.41 | PS11.1x | E25.9% | n/a | ||
| 15303SBio | HK$7.02 | 10.4% | 26.7% | HK$16.8b | HK$8.47 | PE8.2x | E7.5% | 1.3% | ||
| 6826Shanghai Haohai Biological Technology | HK$41.20 | 8.4% | 56.4% | HK$16.0b | HK$66.00 | PE18.8x | E23.0% | 1.0% | ||
| 2162Keymed Biosciences | HK$57.00 | 8.1% | 26.7% | HK$15.8b | HK$75.01 | PS45.1x | E-15.0% | n/a | ||
| 512Grand Pharmaceutical Group | HK$4.31 | 7.8% | 28.3% | HK$15.2b | HK$7.94 | PE6.3x | E8.7% | 3.2% | ||
| 3933United Laboratories International Holdings | HK$8.29 | 2.6% | 152.0% | HK$15.1b | HK$10.66 | PE6.3x | E-0.9% | 4.2% | ||
| 2186Luye Pharma Group | HK$3.80 | 11.4% | 99.0% | HK$14.3b | HK$2.91 | PE29.2x | E26.9% | n/a | ||
| 6185CanSino Biologics | HK$25.05 | 8.7% | -65.7% | HK$12.9b | HK$92.84 | PS13.4x | E124.6% | 3.4% | ||
| 2005SSY Group | HK$4.30 | 4.1% | 32.3% | HK$12.8b | HK$5.99 | PE10.7x | E20.4% | 3.5% | ||
| 719Shandong Xinhua Pharmaceutical | HK$5.67 | 5.6% | 50.0% | HK$11.7b | n/a | PE7x | n/a | 3.8% | ||
| 6660AIM Vaccine | HK$9.55 | 11.3% | -68.1% | HK$11.6b | HK$53.04 | PS8.9x | S53.1% | n/a |